MDNA Life Sciences, Inc. Business Finance Contracts & Agreements
19 Contracts & Agreements
- Note Agreements (6 contracts)
- Stock Agreements (3)
- Underwriting Agreements (5)
- Warrant Agreements (5)
- Agreement between the Company and Christopher C. Mitton dated as of April 24, 2023 Conversion of Deferred Compensation to Common Stock (Filed With SEC on May 2, 2023)
- Form of Underwriting Agreement (Filed With SEC on April 12, 2023)
- Form of Underwriting Agreement (Filed With SEC on April 6, 2023)
- Form of Warrant Agency Agreement (Filed With SEC on April 3, 2023)
- Form of Warrant Agreement (Filed With SEC on April 3, 2023)
- Form of Underwriting Agreement (Filed With SEC on April 3, 2023)
- Form of December 2022 12% Secured Convertible Bridge Warrant (Filed With SEC on January 30, 2023)
- Form of December 2022 12% Secured Convertible Bridge Note (Filed With SEC on January 30, 2023)
- Securities Purchase Agreement for the December 2022 12% Secured Convertible Bridge Notes and December 2022 12% Secured Convertible Bridge Warrants dated December [ ], 2022 (Filed With SEC on January 30, 2023)
- Form of Underwriting Agreement (Filed With SEC on January 30, 2023)
- Form of Underwriting Agreement (Filed With SEC on November 7, 2022)
- Form of 8% Secured Convertible Note (Filed With SEC on August 5, 2022)
- Form of 10% Secured Convertible Note (Filed With SEC on August 5, 2022)
- Form of 12% Secured Convertible Bridge Warrant (Filed With SEC on August 5, 2022)
- Form of 12% Secured Convertible Bridge Note (Filed With SEC on August 5, 2022)
- Form of Securities Purchase Agreement for the 12% Secured Convertible Bridge Notes and 12% Secured Convertible Bridge Warrants (Filed With SEC on August 5, 2022)
- Form of Securities Purchase Agreement and Form of Stock Purchase Warrant for the Series A Convertible Preferred Stock, dated (Filed With SEC on August 5, 2022)
- 2015 Restricted Stock Unit Plan, as amended (Filed With SEC on August 5, 2022)
- Form of Common Stock Certificate (Filed With SEC on August 5, 2022)
